NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation

Melanocytes are dendritic, pigment-producing cells located in the skin and are responsible for its protection against the deleterious effects of solar ultraviolet radiation (UVR), which include DNA damage and elevated reactive oxygen species (ROS). They do so by synthesizing photoprotective melanin...

Full description

Bibliographic Details
Main Authors: Evan L. Carpenter, Alyssa L. Becker, Arup K. Indra
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/6/1531
_version_ 1797446881790394368
author Evan L. Carpenter
Alyssa L. Becker
Arup K. Indra
author_facet Evan L. Carpenter
Alyssa L. Becker
Arup K. Indra
author_sort Evan L. Carpenter
collection DOAJ
description Melanocytes are dendritic, pigment-producing cells located in the skin and are responsible for its protection against the deleterious effects of solar ultraviolet radiation (UVR), which include DNA damage and elevated reactive oxygen species (ROS). They do so by synthesizing photoprotective melanin pigments and distributing them to adjacent skin cells (e.g., keratinocytes). However, melanocytes encounter a large burden of oxidative stress during this process, due to both exogenous and endogenous sources. Therefore, melanocytes employ numerous antioxidant defenses to protect themselves; these are largely regulated by the master stress response transcription factor, nuclear factor erythroid 2-related factor 2 (NRF2). Key effector transcriptional targets of NRF2 include the components of the glutathione and thioredoxin antioxidant systems. Despite these defenses, melanocyte DNA often is subject to mutations that result in the dysregulation of the proliferative mitogen-activated protein kinase (MAPK) pathway and the cell cycle. Following tumor initiation, endogenous antioxidant systems are co-opted, a consequence of elevated oxidative stress caused by metabolic reprogramming, to establish an altered redox homeostasis. This altered redox homeostasis contributes to tumor progression and metastasis, while also complicating the application of exogenous antioxidant treatments. Further understanding of melanocyte redox homeostasis, in the presence or absence of disease, would contribute to the development of novel therapies to aid in the prevention and treatment of melanomas and other skin diseases
first_indexed 2024-03-09T13:46:57Z
format Article
id doaj.art-32d7afca8ead48ecb6e68c8c71920a6a
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T13:46:57Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-32d7afca8ead48ecb6e68c8c71920a6a2023-11-30T20:56:43ZengMDPI AGCancers2072-66942022-03-01146153110.3390/cancers14061531NRF2 and Key Transcriptional Targets in Melanoma Redox ManipulationEvan L. Carpenter0Alyssa L. Becker1Arup K. Indra2Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR 97331, USADepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR 97331, USADepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR 97331, USAMelanocytes are dendritic, pigment-producing cells located in the skin and are responsible for its protection against the deleterious effects of solar ultraviolet radiation (UVR), which include DNA damage and elevated reactive oxygen species (ROS). They do so by synthesizing photoprotective melanin pigments and distributing them to adjacent skin cells (e.g., keratinocytes). However, melanocytes encounter a large burden of oxidative stress during this process, due to both exogenous and endogenous sources. Therefore, melanocytes employ numerous antioxidant defenses to protect themselves; these are largely regulated by the master stress response transcription factor, nuclear factor erythroid 2-related factor 2 (NRF2). Key effector transcriptional targets of NRF2 include the components of the glutathione and thioredoxin antioxidant systems. Despite these defenses, melanocyte DNA often is subject to mutations that result in the dysregulation of the proliferative mitogen-activated protein kinase (MAPK) pathway and the cell cycle. Following tumor initiation, endogenous antioxidant systems are co-opted, a consequence of elevated oxidative stress caused by metabolic reprogramming, to establish an altered redox homeostasis. This altered redox homeostasis contributes to tumor progression and metastasis, while also complicating the application of exogenous antioxidant treatments. Further understanding of melanocyte redox homeostasis, in the presence or absence of disease, would contribute to the development of novel therapies to aid in the prevention and treatment of melanomas and other skin diseaseshttps://www.mdpi.com/2072-6694/14/6/1531NRF2glutathionethioredoxinperoxiredoxinNQO1HO-1
spellingShingle Evan L. Carpenter
Alyssa L. Becker
Arup K. Indra
NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation
Cancers
NRF2
glutathione
thioredoxin
peroxiredoxin
NQO1
HO-1
title NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation
title_full NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation
title_fullStr NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation
title_full_unstemmed NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation
title_short NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation
title_sort nrf2 and key transcriptional targets in melanoma redox manipulation
topic NRF2
glutathione
thioredoxin
peroxiredoxin
NQO1
HO-1
url https://www.mdpi.com/2072-6694/14/6/1531
work_keys_str_mv AT evanlcarpenter nrf2andkeytranscriptionaltargetsinmelanomaredoxmanipulation
AT alyssalbecker nrf2andkeytranscriptionaltargetsinmelanomaredoxmanipulation
AT arupkindra nrf2andkeytranscriptionaltargetsinmelanomaredoxmanipulation